Whalegun
Home

Regeneron Pharmaceuticals REGN paid Crane Strategies $50K for lobbying in Q3 2024 · Budget

Trade details

Type
Lobbying report
Amount
$50,000
Quarter
Q3 2024
Stock
Regeneron Pharmaceuticals REGN
Client
Regeneron Pharmaceuticals
Reported
24/10/10

Up 0.0% from last quarter

What else happened in Regeneron Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/08/31~24/10/30

Regeneron Pharmaceuticals's other lobbying reports

Regeneron Pharmaceuticals REGN paid Crane Strategies $50K for lobbying in Q3 2024 · Budget | Whalegun